Management Consultant Use by Nonprofit Hospitals
https://jamanetwork.com/journals/jama/fullarticle/2854259

To the Editor Dr Bruch and colleagues provided an important analysis of management consulting use in nonprofit hospitals, but a critical methodological limitation warrants consideration before their null finding is interpreted as evidence that consultants add no value.

JAMA Editors' Summary Podcast September 18, 2026
https://jamanetwork.com/journals/jama/fullarticle/2854455

Listen to the JAMA Editor’s Summary for an overview and discussion of the important articles appearing in JAMA.

FDA Approves New Treatment for Advanced Pancreatic Cancer
https://jamanetwork.com/journals/jama/fullarticle/2854429

The US Food and Drug Administration (FDA) approved a first-in-class therapy for patients with metastatic pancreatic cancer.

Mpox Virus Transitions Toward Endemicity
https://jamanetwork.com/journals/jama/fullarticle/2854428

Surveillance data from the US Centers for Disease Control and Prevention (CDC) suggest that the clade IIb mpox virus is transitioning toward endemic circulation.

FDA Approves 2 New Alzheimer Disease Blood Tests
https://jamanetwork.com/journals/jama/fullarticle/2854427

The US Food and Drug Administration (FDA) approved 2 new blood tests to detect Alzheimer disease in adults with cognitive symptoms, including 1 for those as young as 40 years old.

Error in Funding/Support
https://jamanetwork.com/journals/jamaneurology/fullarticle/2854367

In the Original Investigation titled “Automated Speech Analysis to Identify Clinical, Anatomical, and Pathological Variants of Primary Progressive Aphasia,” published on August 3, 2026, there was an error in the Funding/Support section. This section should have read, “This work was supported by National Institutes of Health (NIH) grants R00AG066934 and RF1AG091509 (Dr Vonk), R01NS050915, K24DC015544, and R01AG075775 (Dr Gorno-Tempini), P01AG019724 (Drs Gorno-Tempini, Rosen, and Seeley), and U19AG063911 (Dr Rosen) and by NIH/National Institute on Deafness and Other Communication Disorders grant R01DC016291 (Dr Henry). This work was also supported by a 2025 UCSF Catalyst Award for the Development of Diagnostics, Devices, Therapeutics and Digital/Computational Health (Dr Vonk), cofunded by the UCSF Weill Institute for Neurosciences.” This article was corrected online.

Unprecedented In Vivo MRI Resolution of Basal Ganglia at 11.7 T
https://jamanetwork.com/journals/jamaneurology/fullarticle/2854366

This case report describes 11.7-T in vivo human brain magnetic resonance imaging (MRI) of the basal ganglia in 2 healthy volunteers.

Portable Low-Field MRI of the Brain in Clinic and Community Settings
https://jamanetwork.com/journals/jamaneurology/fullarticle/2854365

This cohort study evaluates portable, low-field magnetic resonance imaging (MRI) against conventional MRI in memory clinic and community cohorts.

A Harmonized Visual Reading Framework for Tau PET Staging in Alzheimer Disease
https://jamanetwork.com/journals/jamaneurology/fullarticle/2854364

This cross-sectional study develops and validates a harmonized tau positron emission tomography (PET) visual reading framework across radiotracers that stages tau burden into 5 classes.

When to Use the HINTS Examination in Patients With Dizziness
https://jamanetwork.com/journals/jamaneurology/fullarticle/2854363

This narrative review discusses when it is appropriate to use the Head Impulse, Nystagmus, Test of Skew (HINTS) examination to assess patients with dizziness.

Risk Stratification in Steatotic Liver Disease
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2854077

With the rise in steatotic liver disease (SLD) and the limited capacity of hepatology specialists, primary care is under growing pressure to identify high-risk patients and establish clear referral pathways to hepatology. The American Association for the Study of Liver Disease (AASLD) 2023 national guidelines recommend the Fibrosis-4 (FIB-4) Index as the primary noninvasive test (NIT) to screen at-risk adults for advanced fibrosis before confirmatory testing and referral to hepatology. Ongoing advances in SLD-related NITs provide an opportunity for primary care to consider improved screening pathways.

Antidiscrimination Laws and Kidney Transplant for Patients With Developmental Disabilities
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2854076

This cohort study explores the association between transplant antidiscrimination state laws and rates of transplant evaluation and receipt among patients with end-stage kidney disease with or without intellectual and/or developmental disabilities.

Steatotic Liver Disease Risk Scores to Predict Cirrhosis and Hepatocellular Carcinoma
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2854075

This cohort study assesses the clinical utility of steatotic liver disease risk scores for predicting cirrhosis and hepatocellular carcinoma in patients with noncirrhotic steatotic liver disease.

Buprenorphine via Telehealth
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2854074

This Viewpoint calls for further research to guide clinicians and policymakers in increasing access and effective use of telehealth prescribing of buprenorphine for pregnant and postpartum women.

Hearing Aids for Mild to Moderate Hearing Loss in Adults
https://jamanetwork.com/journals/jama/fullarticle/2854266

To the Editor A recent JAMA Insights article provided a timely discussion on the role of over-the-counter (OTC) hearing aids. It had been previously demonstrated that self-fit OTC devices can achieve outcomes comparable to audiologist-fit hearing aids, which is particularly relevant in the current context of changing approaches to hearing aid provision. It is encouraging to see this issue addressed in a high-impact journal, increasing awareness among clinicians and the public.

Hearing Aids for Mild to Moderate Hearing Loss in Adults—Reply
https://jamanetwork.com/journals/jama/fullarticle/2854265

In Reply In a letter about our recent Insights article on hearing aids for adults with mild to moderate hearing loss, Dr Kim raises an important point regarding the role of professional involvement, and specifically informational counseling in patients with hearing loss and comorbid chronic tinnitus who pursue OTC amplification.

Medicare Advantage Enrollment and Access to Kidney Transplant After the 21st Century Cures Act
https://jamanetwork.com/journals/jama/fullarticle/2854264

This cohort study characterizes differences in transplant access between Medicare Advantage and traditional Medicare beneficiaries with end-stage kidney disease (ESKD) during the first 3 years after the 21st Century Cures Act (2021-2023), a period of rapid Medicare Advantage enrollment growth.

Protecting Patients From Politicization of Federal Science
https://jamanetwork.com/journals/jama/fullarticle/2854263

This Perspective discusses new proposed federal rules regarding research funding; the ways these rules could affect patients, communities, and taxpayers; and how federally supported research has benefitted public health.

Review of Vaccines for Cancer
https://jamanetwork.com/journals/jama/fullarticle/2854262

This translational science review examines antigen-based cancer vaccines, which help patients develop immunity to the cellular protein expressed by cancer by stimulating the adaptive immune system.

Medicolegal Evaluations for Asylum Seekers
https://jamanetwork.com/journals/jama/fullarticle/2854454

This JAMA Insights discusses the importance of medicolegal evaluations for those seeking asylum and encourages clinicians to complete additional training to conduct these evaluations.